MS
Clinical trials for MS explained in plain language.
Never miss a new study
Get alerted when new MS trials appear
Sign up with your email to follow new studies for MS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CAR-T therapy for autoimmune diseases: trial pulled before start
Disease control TerminatedThis early-phase trial aimed to test a CD19-targeted CAR-T cell therapy (RD06-04) in people with autoimmune diseases like lupus, multiple sclerosis, and myasthenia gravis. The goal was to see if the treatment was safe and could reduce disease activity. However, the study was with…
Matched conditions: MS
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
New app aims to close depression care gaps for MS patients
Symptom relief OngoingThis study tests a smartphone app called MS CATCH that lets people with multiple sclerosis regularly report their mood symptoms. The information is shared with their neurologist, who gets alerts if there are concerns. The goal is to improve depression screening and care. About 10…
Matched conditions: MS
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated May 17, 2026 03:09 UTC
-
MS study aims to spot cognitive decline with advanced MRI
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing whether a new type of MRI can predict memory and thinking problems in people with multiple sclerosis (MS). Researchers will scan the brains of 75 adults with MS and compare the images to their performance on thinking tests. The goal is to find better ways to…
Matched conditions: MS
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated May 17, 2026 02:58 UTC